Bernard Hoet, MD, FFPM

Vice President Medical Affairs
GSK, Wavre, Belgium

Disclosure: GSK group of companies (Individual(s) Involved: Self): Shareholder

Presentation(s):

• 34 - Impact of Universal Mass Vaccination Programs of Children Against Hepatitis a with 2-dose and 1-dose Schedules: A Systematic Literature Review

  Oral Abstract